Hemp Biomass Products

By |2018-10-10T07:16:01+00:00Oct,18 10|Categories: CBD, Hemp|Tags: , , , , , , , , , , |

Hemp Biomass Products Industrial Hemp is an incredibly versatile plant renowned for it's long history of human use to produce wide range of products - from medicine (CBD) to food (oil and seeds) to fibre (stem) and much more. Hemp biomass can also be used to produce energy by combustion, fermentation and other processes. Hemp plants [...]

Pharmaceutical Grade Cannabinoids for Clinical Trials

By |2018-10-06T08:43:36+00:00Oct,18 6|Categories: Medical Cannabis|Tags: , , , , , , , , , , , |

Why Pharmaceutical Grade Cannabinoids Are Needed for Clinical Trials Recently, Tilray made big news announcing that they would be importing Canadian cannabis into the USA for clinical trials. This ruffled some feathers in the US cannabis industry, who operate under state legal programs while the US Federal law insists that cannabis is a highly dangerous and [...]

CBD Oil vs Hemp Oil vs Hemp Seed Oil – What’s the difference

By |2018-09-29T06:22:13+00:00Sep,18 29|Categories: Medical Cannabis|Tags: , , , , , , |

CBD Oil vs Hemp Oil vs Hemp Seed Oil - What's the difference? CBD Oil, Hemp Oil and Hemp Seed Oil are related products which can be produced from the Hemp plan, Cannabis Sativa. Consumers and health professionals often get confused by the differences between the different products hemp oil products. Hemp Seed Oil Hemp Seed Oil [...]

Pharma Grade CBD Products to be Rescheduled

By |2018-09-29T00:06:18+00:00Sep,18 29|Categories: Medical Cannabis|Tags: , , , , , , , , |

Pharma Grade CBD Products to be Rescheduled to Schedule V Pharma Grade CBD Products such as Epidiolex will be Schedule V - comparable to codeine-containing cough syrups - indicating a low potential for abuse and effectiveness as a therapeutic drug. The Drug Enforcement Agency published a notification on the FDA CBD rescheduling in the Federal Register. "With [...]

CBD Isolate Drugs Rescheduled by the FDA

By |2018-09-28T06:03:43+00:00Sep,18 28|Categories: CBD|Tags: , , , , , , , , , |

CBD Isolate Drugs Rescheduled by the FDA CBD isolate based drug Epidolex has been removed from Schedule I and placed in Schedule V which will make access to the drug much simpler for patients who can afford it. The rescheduling is a major breakthrough in the medical cannabis and hemp CBD industry because it finally recognises [...]

Coca Cola’s CBD Move and what it means for the Cannabis Industry

By |2018-09-24T00:06:10+00:00Sep,18 23|Categories: CBD|Tags: , , , , , , , , , |

Will Coca Cola Become an Infused Beverage Leader? Coca-Cola is looking at Cannabis derived ingredient - CBD (Cannabidiol) as a possible ingredient in health drinks. While this may seem strange at first we should remember that Coca Cola started out as a tonic containing botanical extracts including cocaine. Coca-Cola is in talks with a major Canadian cannabis [...]

Hemp industry turns to Pharma tech to meet growing demand for Cannabidiol

By |2018-05-11T03:34:15+00:00May,18 11|Categories: Medical Cannabis|

Hemp industry turns to Pharma tech to meet growing demand for Cannabidiol Rhizo Sciences partners with Thar Process to extract CBD from hemp at industrial scale   Seattle, May 10, 2018   The hemp industry is undergoing a renaissance due to an explosion of interest in Cannabidiol, (aka CBD) but it’s struggling to keep up with [...]

African Medical Cannabis Exported to Canada in Historic First for Industry

By |2018-05-04T04:07:38+00:00May,18 4|Categories: International Cannabis|

Medical Cannabis: Out of Africa Africa is one of the homelands of modern medical cannabis. Many of the most prominent medical cannabis genetics have African Ancestry, and names such as Durban Poison (South African), Malawi Gold, and Moroccan Hash are touchstones for cannabis geneticists. A treasure trove of landrace strains are still preserved around the continent [...]

New Zealand Medical Cannabis Export Facility

By |2018-02-26T21:14:33+00:00Feb,18 1|Categories: International Cannabis|

Ruatoria-based Hikurangi Group has signed an agreement to work with Rhizo Sciences LLC, a cannabis industry development and distribution company based in Seattle, Washington, USA. Rhizo Sciences develops and manages medical cannabis cultivation, extraction and manufacturing facilities internationally. Their international experience and turnkey systems will enable Hikurangi Group to rapidly expand their Ruatoria medical cannabis cultivation [...]

International Medical Cannabis Market Analysis

By |2018-01-02T03:12:20+00:00Jan,18 2|Categories: Medical Cannabis|

Medical Cannabis is Going Global The medical cannabis industry is booming, growing faster than any industry segment since dot.com boom. It sounds like an investor's dream: Fast moving, high growth, high return, and a queue of institutional investors waiting on the sidelines to pour in capital following legalisation, including big pharma, big food, big alcohol, and [...]